Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia... Show more
Industry ServicestotheHealthIndustry
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TTOP | 18.25 | 3.08 | +20.33% |
| 21Shares FTSE Crypto 10 Index ETF | |||
| ETY | 14.38 | 0.04 | +0.28% |
| Eaton Vance Tax-Managed Diversified Equity Income Fund | |||
| GDEC | 40.52 | 0.06 | +0.15% |
| FT Vest U.S. Eq Mod Buffr ETF - Dec | |||
| APRJ | 24.94 | N/A | N/A |
| Innovator Premium Income 30 Bar ETF -Apr | |||
| CRWG | 19.67 | -0.93 | -4.51% |
| Leverage Shares 2X Long CRWV Daily ETF | |||
A.I.dvisor indicates that over the last year, PRVA has been loosely correlated with RIOT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRVA jumps, then RIOT could also see price increases.
| Ticker / NAME | Correlation To PRVA | 1D Price Change % | ||
|---|---|---|---|---|
| PRVA | 100% | -0.38% | ||
| RIOT - PRVA | 46% Loosely correlated | -5.48% | ||
| EVCM - PRVA | 45% Loosely correlated | -0.41% | ||
| EVTC - PRVA | 45% Loosely correlated | +0.54% | ||
| SPT - PRVA | 45% Loosely correlated | -0.50% | ||
| QLYS - PRVA | 45% Loosely correlated | -0.13% | ||
More | ||||
| Ticker / NAME | Correlation To PRVA | 1D Price Change % |
|---|---|---|
| PRVA | 100% | -0.38% |
| Services to the Health Industry industry (43 stocks) | 22% Poorly correlated | +0.67% |
| Health Services industry (242 stocks) | -1% Poorly correlated | +0.79% |
PRVA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 17, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on July 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PRVA as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
PRVA moved below its 50-day moving average on July 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PRVA crossed bearishly below the 50-day moving average on August 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for PRVA entered a downward trend on August 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRVA advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .
PRVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PRVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.448) is normal, around the industry mean (7.638). PRVA has a moderately high P/E Ratio (96.091) as compared to the industry average of (46.808). PRVA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.726). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (1.169) is also within normal values, averaging (6.460).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.